(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE COMPOSTOS PARA TRATAR DISTÚRBIOS HEMATOLÓGICOS

Em AnáliseInvention PatentPCT · US2018058194

Application data

Number

112020008214

Type

Invention Patent

Filing

10/30/2018

Publication

10/27/2020

PCT

US2018058194

Progress at the INPI

Under appeal
  1. Filing10/30/18
  2. Publication10/27/20
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application is under appeal: the INPI has yet to review the decision.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/03/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CURIS, INC.

US

See this company's full portfolio

Inventors

R. B. (pessoa física)

US

Technical data

Priority claims

US

62/579.502 · 10/31/2017

Abstract

A presente invenção fornece métodos de tratamento de distúrbios hematológicos e tumores malignos sólidos, utilizando compostos de indazol substituídos e sais farmaceuticamente aceitáveis destes. Os compostos inibem as quinases IRAK4 e BCL-2.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Petição de recurso

#12.2

Recurso: Petição 870260016373, de 23/02/2026

03/03/2026

RPI 2878

Indeferimento

#9.2

12/23/2025

RPI 2868

Conhecimento de parecer técnico

#7.1

08/05/2025

RPI 2848

Parecer de pré-exame

#6.23

07/26/2022

RPI 2690

Adição na publicação

#15.35

12/07/2021

RPI 2657

Notificação de entrada na fase nacional - PCT

#1.3

10/27/2020

RPI 2599

Alteração de dados cadastrais

#1.1

10/06/2020

RPI 2596

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.